Medicine & Life Sciences
130-nm albumin-bound paclitaxel
7%
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
10%
2-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-3-ylamino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide
7%
Adenocarcinoma
14%
Amyloid Precursor Protein Secretases
15%
Bevacizumab
8%
Biomarkers
7%
Carcinoid Heart Disease
16%
Carcinoid Tumor
21%
Cetuximab
7%
Circulating Tumor DNA
31%
Clinical Trials
20%
Colonic Neoplasms
7%
Colorectal Neoplasms
85%
Confidence Intervals
11%
Costs and Cost Analysis
8%
CpG Islands
11%
Databases
9%
Drug Approval
7%
Drug Therapy
16%
Epidemiology
10%
ErbB Receptors
7%
Fluorouracil
10%
Gastro-enteropancreatic neuroendocrine tumor
13%
HMPL-013
16%
Incidence
10%
Irinotecan
13%
Liver
9%
Lymph Node Excision
10%
Lymph Nodes
10%
Microsatellite Instability
10%
Mutation
13%
National Cancer Institute (U.S.)
10%
Neoadjuvant Therapy
10%
Neoplasm Metastasis
14%
Neoplasms
37%
Neuroendocrine Carcinoma
25%
Neuroendocrine Tumors
100%
Octreotide
7%
Pancreatic Neoplasms
7%
pembrolizumab
11%
Peptide Receptors
9%
Population
8%
Progression-Free Survival
12%
Radioisotopes
8%
Rectal Neoplasms
16%
saracatinib
9%
Streptozocin
7%
Survival
35%
Therapeutics
19%